Skip to content
HowShorted

Tango Therapeutics, Inc. short interest in 2023

In 2023, Tango Therapeutics, Inc.'s disclosed short interest ran from 1.62% of shares outstanding on 13 Jan 2023 to 11.51% on 29 Dec 2023, a change of +9.89 percentage points. The year's high was 11.51% on 29 Dec 2023 and its low 1.62% on 13 Jan 2023, averaging 4.48% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.04 days on 30 Nov 2023. Full history: Tango Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Tango Therapeutics, Inc. in 2023

2023 in figures

Start of year
1.62% (13 Jan 2023)
End of year
11.51% (29 Dec 2023)
Change
+9.89 pp
High
11.51% (29 Dec 2023)
Low
1.62% (13 Jan 2023)
Average
4.48%
Highest days to cover
19.04 (30 Nov 2023)
SEC filings marked
8

Every report in 2023

Tango Therapeutics, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20231.62%11.51
31 Jan 20231.68%7.60
15 Feb 20232.42%6.62
28 Feb 20232.61%12.40
15 Mar 20232.66%15.85
31 Mar 20232.91%12.9010-K filed, results (8-K)
14 Apr 20232.85%14.20
28 Apr 20232.51%11.35
15 May 20232.06%11.5910-Q filed, results (8-K)
31 May 20232.08%8.50
15 Jun 20231.70%3.91
30 Jun 20231.72%8.51
14 Jul 20231.70%17.69
31 Jul 20231.84%15.00
15 Aug 20233.16%1.0010-Q filed, results (8-K)
31 Aug 20232.92%5.80
15 Sep 20234.00%4.39
29 Sep 20235.99%4.05
13 Oct 20237.76%2.30
31 Oct 20239.54%7.17
15 Nov 202310.56%12.5610-Q filed, results (8-K)
30 Nov 202311.03%19.04
15 Dec 202310.63%15.13
29 Dec 202311.51%17.23

See also: Tango Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.